Holly Liptak is an Editorial Assistant for Healio, a publication focused on providing healthcare professionals with the latest news and information in their field. Holly covers a wide range of topics in the medical field, including advancements in cancer treatment, sleep hygiene, and strategies for preventing diseases like hepatitis C.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Holly Liptak's coverage mainly focuses on healthcare and pharmaceuticals, with a strong emphasis on citing data. She would likely be receptive to pitches from experts who can provide in-depth analysis or commentary based on robust data related to developments in cancer treatment, lung cancer, and other medical topics she covers.
Given her focus on specific medical conditions and treatments, Holly may welcome insights from professionals directly involved in the research or treatment of these conditions. However, she might also consider expert opinions that offer broad perspectives across similar areas of healthcare & pharmaceuticals.
While Holly doesn't have a specified geographic focus, it’s important for any outreach to align with global trends and developments within the healthcare and pharmaceutical sphere.
This information evolves through artificial intelligence and human feedback. Improve this profile .
In this video, Alokkumar Jha, PhD, MSc, BE, spoke with Healio about key presentations from the American Neurological Association annual meeting.
Video Player is loading. Play Video Play Mute Current Time Duration Loaded
In this video, Alokkumar Jha, PhD, MSc, BE, spoke with Healio about the role that age and sex play in the severity of an ischemic stroke.
Video Player is loading. Play Video Play Mute Current Time Duration
Video Player is loading. Play Video Play Mute Current Time Duration Loaded
The FDA has approved obecabtagene autoleucel for the treatment of adults with relapsed refractory B-cell precursor acute lymphoblastic leukemia.
By: Heather Biele, Holly Liptak
Healio spoke with Ahmad Anouti, MD, a pediatric resident at UT Southwestern Medical Center, about a presentation at The Liver Meeting on how blocking nuclear factor kappa B could correct cellular defects in biliary atresia.
By: Heather Biele, Holly Liptak
Healio spoke with Ahmad Anouti, MD, a pediatric resident at UT Southwestern Medical Center, about his patient keynote address at The Liver
By: Heather Biele, Holly Liptak
Video Player is loading. Play Video Play Mute Current Time Duration Loaded
By: Heather Biele, Holly Liptak
Healio spoke with Ahmad Anouti, MD, about a presentation at The Liver Meeting on the prognostic value of reaching normal bilirubin levels after Kasai portoenterostomy in biliary atresia.
(833) 317-6278 
